First targeted radioligand therapy to demonstrate significant and clinically meaningful impact in first-line advanced gastroeneropancreatic neuroendocrine tumors

by VHIO

It has been demonstrated that first-line treatment with 177LU-DOTATATE combined with long-acting octreotide significantly improves progression-free survival (PFS) in patients with recently diagnosed s...

Read more
Subscribe to Directory
Write an Article

Recent News

¿Por qué no es recomendable llevar la ...

La mejor actitud que podemos adoptar es la de trat...

Exposure to Heat and Cold During Pregnan...

The research team observed changes in head circumf...

Using mobile RNAs to improve Nitrogen a...

AtCDF3 gene induced greater production of sugars a...

Highlight

Eosinófilos. ¿Qué significa tener val...

by Labo'Life

​En nuestro post hablamos sobre este interesante tipo de célula del...

Telum Therapeutics Secures €18 Million...

by Telum Therapeutics

Telum Therapeutics, a biotechnology company leveraging proprietary met...

Photos Stream